Researchers in Japan have unraveled the mystery of why human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells undergo programmed cell death (apoptosis) when cultured in isolation. By unlocking the potential of cell therapy techniques, the discovery promises new hope to sufferers of debilitating degenerative diseases.